KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $763000.0.

  • Opko Health's Gains from Investment Securities changed N/A to $763000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year increase of 969.34%. This contributed to the annual value of $45.5 million for FY2024, which is 1228.24% down from last year.
  • According to the latest figures from Q3 2025, Opko Health's Gains from Investment Securities is $763000.0.
  • In the past 5 years, Opko Health's Gains from Investment Securities ranged from a high of $23.4 million in Q4 2023 and a low of -$27.4 million during Q4 2022
  • Over the past 5 years, Opko Health's median Gains from Investment Securities value was $960000.0 (recorded in 2023), while the average stood at $1.5 million.
  • Over the last 5 years, Opko Health's Gains from Investment Securities had its largest YoY gain of 33565.63% in 2022, and its largest YoY loss of 288892.28% in 2022.
  • Opko Health's Gains from Investment Securities (Quarter) stood at $984000.0 in 2021, then crashed by 2888.92% to -$27.4 million in 2022, then skyrocketed by 185.26% to $23.4 million in 2023, then crashed by 73.47% to $6.2 million in 2024, then plummeted by 87.71% to $763000.0 in 2025.
  • Its Gains from Investment Securities stands at $763000.0 for Q3 2025, versus $17.8 million for Q2 2025 and $2.1 million for Q1 2025.